Atlanta, GA, United States of America

Taeyoung Kim

This inventor holds 2 USPTO granted patents. Top assignees: Georgia Tech Research Corporation, Mepsgen Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taeyoung Kim. Retrieved from https://idiyas.com/inventor/taeyoung-kim-xotug5fp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Taeyoung Kim: Innovator in Microengineered Tissue Barrier Systems

Introduction

Taeyoung Kim is a prominent inventor based in Atlanta, GA (US), known for his contributions to the field of microengineered tissue barrier systems. With a total of 2 patents, his work focuses on advancing drug development and toxicity assessment through innovative microfluidic devices.

Latest Patents

Kim's latest patents include a microengineered tissue barrier system, which relates to a microfluidic device designed to simulate the structure and function of an in vivo tissue barrier. This invention aims to replace traditional animal models by providing a model for new drug development and toxicity assessment. Additionally, he has developed a microengineered tissue barrier device that enhances the understanding of connective tissue barriers.

Career Highlights

Throughout his career, Taeyoung Kim has worked with notable organizations, including the Georgia Tech Research Corporation and Mepsgen Co., Ltd. His expertise in microfluidic technology has positioned him as a leader in the field, contributing to significant advancements in biomedical research.

Collaborations

Kim has collaborated with talented individuals such as YongTae Kim and Jiho Song, further enriching his research and development efforts.

Conclusion

Taeyoung Kim's innovative work in microengineered tissue barrier systems exemplifies the potential of technology to transform drug development and toxicity assessment. His contributions continue to pave the way for future advancements in biomedical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…